Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
vav, a novel human oncogene, was originally generated in vitro by replacement of its normal 5' coding sequences with sequences from pSV2neo DNA, cotransfected as a selectable marker (S. Katzav, D. Martin-Zanca, and M. Barbacid, EMBO J. 8:2283-2290, 1989). The vav proto-oncogene is normally expressed...
Enregistré dans:
| Publié dans: | Mol Cell Biol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
1991
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC359873/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2005887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.11.4.1912-1920.1991 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
